Market Closed -
Bombay S.E.
06:00:49 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
802.4
INR
|
-0.06%
|
|
+3.94%
|
+16.70%
|
Fiscal Period: March |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
199,033
|
336,359
|
428,177
|
779,863
|
-
|
-
|
Enterprise Value (EV)
1 |
203,285
|
340,500
|
420,386
|
766,260
|
766,280
|
756,025
|
P/E ratio
|
-130
x
|
55.6
x
|
38.8
x
|
59.5
x
|
49.9
x
|
39.7
x
|
Yield
|
-
|
-
|
0.23%
|
0.16%
|
0.18%
|
0.23%
|
Capitalization / Revenue
|
7.95
x
|
8.56
x
|
9.38
x
|
11.4
x
|
9.34
x
|
7.47
x
|
EV / Revenue
|
8.12
x
|
8.66
x
|
9.21
x
|
11.2
x
|
9.17
x
|
7.24
x
|
EV / EBITDA
|
50.3
x
|
36.1
x
|
33.9
x
|
40.9
x
|
33.6
x
|
26.6
x
|
EV / FCF
|
-
|
182
x
|
48.1
x
|
311
x
|
116
x
|
54.3
x
|
FCF Yield
|
-
|
0.55%
|
2.08%
|
0.32%
|
0.86%
|
1.84%
|
Price to Book
|
3.53
x
|
5.35
x
|
5.78
x
|
8.53
x
|
7.36
x
|
6.27
x
|
Nbr of stocks (in thousands)
|
965,945
|
969,613
|
970,923
|
971,912
|
-
|
-
|
Reference price
2 |
206.0
|
346.9
|
441.0
|
802.4
|
802.4
|
802.4
|
Announcement Date
|
5/28/21
|
5/25/22
|
5/16/23
|
-
|
-
|
-
|
Fiscal Period: Maart |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
25,047
|
39,315
|
45,626
|
68,521
|
83,522
|
104,461
|
EBITDA
1 |
4,039
|
9,426
|
12,405
|
18,752
|
22,818
|
28,465
|
EBIT
1 |
2,298
|
7,214
|
10,083
|
16,167
|
19,577
|
24,611
|
Operating Margin
|
9.17%
|
18.35%
|
22.1%
|
23.59%
|
23.44%
|
23.56%
|
Earnings before Tax (EBT)
1 |
-686.5
|
7,389
|
10,637
|
16,248
|
19,529
|
24,601
|
Net income
1 |
-1,145
|
6,050
|
11,035
|
13,225
|
15,957
|
20,246
|
Net margin
|
-4.57%
|
15.39%
|
24.19%
|
19.3%
|
19.1%
|
19.38%
|
EPS
2 |
-1.590
|
6.240
|
11.36
|
13.50
|
16.10
|
20.19
|
Free Cash Flow
1 |
-
|
1,872
|
8,736
|
2,466
|
6,625
|
13,914
|
FCF margin
|
-
|
4.76%
|
19.15%
|
3.6%
|
7.93%
|
13.32%
|
FCF Conversion (EBITDA)
|
-
|
19.86%
|
70.42%
|
13.15%
|
29.03%
|
48.88%
|
FCF Conversion (Net income)
|
-
|
30.94%
|
79.16%
|
18.64%
|
41.52%
|
68.73%
|
Dividend per Share
2 |
-
|
-
|
1.000
|
1.312
|
1.475
|
1.829
|
Announcement Date
|
5/28/21
|
5/25/22
|
5/16/23
|
-
|
-
|
-
|
Fiscal Period: March |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
7,956
|
8,019
|
10,002
|
10,183
|
9,742
|
9,388
|
10,003
|
11,371
|
11,412
|
12,145
|
12,850
|
16,799
|
16,892
|
17,895
|
-
|
EBITDA
1 |
1,601
|
1,681
|
3,600
|
3,620
|
2,458
|
2,103
|
2,644
|
3,188
|
3,134
|
3,403
|
3,374
|
4,581
|
4,673
|
4,990
|
-
|
EBIT
1 |
1,117
|
1,205
|
-
|
-
|
-
|
-
|
2,072
|
2,612
|
2,564
|
2,800
|
2,816
|
3,775
|
3,792
|
4,132
|
-
|
Operating Margin
|
14.04%
|
15.03%
|
-
|
-
|
-
|
-
|
20.72%
|
22.97%
|
22.47%
|
23.05%
|
21.91%
|
22.47%
|
22.45%
|
23.09%
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-
|
-
|
2,164
|
2,652
|
2,814
|
3,007
|
3,035
|
3,849
|
4,164
|
4,314
|
-
|
Net income
1 |
-
|
-
|
-
|
-
|
-
|
-
|
1,728
|
4,574
|
2,224
|
2,509
|
2,401
|
3,160
|
3,456
|
3,520
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
17.28%
|
40.22%
|
19.49%
|
20.66%
|
18.68%
|
18.81%
|
20.46%
|
19.67%
|
-
|
EPS
2 |
1.000
|
0.7500
|
-
|
1.490
|
1.960
|
1.270
|
1.780
|
4.710
|
2.290
|
2.580
|
2.460
|
3.240
|
3.397
|
3.525
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1.000
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/6/21
|
5/28/21
|
8/10/21
|
11/12/21
|
2/12/22
|
5/25/22
|
8/10/22
|
11/1/22
|
2/2/23
|
5/16/23
|
8/7/23
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
4,252
|
4,141
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
7,791
|
13,603
|
13,582
|
23,837
|
Leverage (Debt/EBITDA)
|
1.053
x
|
0.4393
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
1,872
|
8,736
|
2,466
|
6,625
|
13,914
|
ROE (net income / shareholders' equity)
|
-3.36%
|
10.3%
|
16.1%
|
15.1%
|
15.5%
|
16.7%
|
ROA (Net income/ Total Assets)
|
-2.2%
|
6.91%
|
11.4%
|
11.7%
|
12.3%
|
13.5%
|
Assets
1 |
52,102
|
87,600
|
96,455
|
113,463
|
129,470
|
150,202
|
Book Value Per Share
2 |
58.40
|
64.80
|
76.30
|
94.10
|
109.0
|
128.0
|
Cash Flow per Share
2 |
-
|
7.720
|
12.50
|
12.60
|
17.00
|
20.00
|
Capex
1 |
1,184
|
5,613
|
3,356
|
10,631
|
15,107
|
12,093
|
Capex / Sales
|
4.73%
|
14.28%
|
7.36%
|
15.51%
|
18.09%
|
11.58%
|
Announcement Date
|
5/28/21
|
5/25/22
|
5/16/23
|
-
|
-
|
-
|
Last Close Price
802.4
INR Average target price
844.2
INR Spread / Average Target +5.21% Consensus |
1st Jan change
|
Capi.
|
---|
| +16.70% | 9.35B | | -14.92% | 84.68B | | +13.30% | 81.12B | | +10.92% | 29.4B | | -12.71% | 16.73B | | -3.06% | 16.36B | | -2.63% | 14.92B | | -31.75% | 11.77B | | -1.42% | 11.72B | | +27.44% | 11.71B |
Other Healthcare Facilities & Services
|